Europe Epilepsy Monitoring Devices Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2023 –2030 |
 Marktgröße (Basisjahr) | USD 142.70 Billion |
 Marktgröße (Prognosejahr) | USD 216.73 Billion |
 CAGR |
% |
| Wichtige Marktteilnehmer |
>Europäischer Markt für Epilepsieüberwachungsgeräte nach Produkttyp ( tragbare Geräte , intelligente Geräte und konventionelle Geräte), Typ (fokale Anfälle und generalisierte Anfälle), Patiententyp (Kinder, Geriatrie und Erwachsene), Endbenutzer (Krankenhäuser, häusliche Pflegeeinrichtungen, neurologische Zentren, Diagnosezentren, ambulante chirurgische Zentren und Kliniken und andere), Vertriebskanal (Einzelhandel, Online-Verkäufe, Direktausschreibungen und andere) – Branchentrends und Prognose bis 2030.
Marktgröße für Epilepsieüberwachungsgeräte in Europa
Die steigende Nachfrage nach tragbaren Epilepsieüberwachungsgeräten trägt dazu bei, das allgemeine Marktwachstum anzukurbeln. Die wachsenden staatlichen Investitionen in Epilepsieprojekte tragen ebenfalls zum Marktwachstum bei. Die wichtigsten Marktteilnehmer konzentrieren sich stark auf die Entwicklung verschiedener neuer Epilepsieüberwachungsgeräte. Darüber hinaus trägt auch die zunehmende Prävalenz von Epilepsie zur steigenden Nachfrage auf dem Markt bei.
Der europäische Markt für Epilepsieüberwachungsgeräte wird im Prognosezeitraum von 2023 bis 2030 voraussichtlich ein Marktwachstum verzeichnen. Data Bridge Market Research analysiert, dass der Markt im Prognosezeitraum von 2023 bis 2030 mit einer durchschnittlichen jährlichen Wachstumsrate (CAGR) von 5,4 % wächst und von 142,70 Millionen USD im Jahr 2022 auf 216,73 Millionen USD im Jahr 2030 ansteigen dürfte.
|
Berichtsmetrik |
Details |
|
Prognosezeitraum |
2023 bis 2030 |
|
Basisjahr |
2022 |
|
Historisches Jahr |
2021 (anpassbar auf 2020–2015) |
|
Quantitative Einheiten |
Umsatz in Mio. USD |
|
Abgedeckte Segmente |
Nach Produkttyp (tragbare Geräte, Smart-Geräte und konventionelle Geräte), Typ (fokale Anfälle und generalisierte Anfälle), Patiententyp (Kinder, Geriatrie und Erwachsene), Endbenutzer (Krankenhäuser, häusliche Pflegeeinrichtungen, neurologische Zentren, Diagnosezentren, ambulante chirurgische Zentren und Kliniken und andere), Vertriebskanal (Einzelhandel, Online-Verkäufe, Direktausschreibungen und andere) |
|
Abgedeckte Länder |
Deutschland, Großbritannien, Frankreich, Italien, Spanien, Russland, Niederlande, Schweiz, Belgien, Türkei, Dänemark, Schweden, Norwegen, Polen, Finnland, Rest von Europa. |
|
Abgedeckte Marktteilnehmer |
NIHON KOHDEN CORPORATION., Masimo, Apple Inc., Natus Medical Incorporated., Owlet, Neurotech, LLC, Epilert, ActiGraph, LLC., Empatica Inc., Epiview, LivAssured, Advanced Brain Monitoring, Inc., epihunter, iBaby Labs, Inc., Epi USA, Neurosoft, Snuza, Medpage Ltd, ITS Designs Ltd, HiPass Design LLC, Frequency Precision., Vahlkamp International und Epilepsy Alarms UK, unter anderem.
|
Marktdefinition
Epilepsie ist eine Störung des zentralen Nervensystems (neurologische Erkrankung), bei der die Gehirnaktivität abnorm wird, was zu Anfällen oder Phasen ungewöhnlichen Verhaltens, ungewöhnlicher Empfindungen und manchmal Bewusstseinsverlust führt. Epileptische Anfälle können von kurzen und kaum wahrnehmbaren Phasen bis hin zu langen Phasen heftigen Zitterns aufgrund abnormer elektrischer Aktivität im Gehirn reichen. Die häufigste Anfallsart ist der Krampf, bei dem es zu unwillkürlichen Muskelkontraktionen kommt.
Tonisch-klonische Anfälle treten mit einer Kontraktion der Gliedmaßen auf, gefolgt von ihrer Streckung und Wölbung des Rückens, die 10–30 Sekunden dauert. Myoklonische Anfälle beinhalten sehr kurze Muskelkrämpfe in einigen Bereichen oder am ganzen Körper.
Marktdynamik für Epilepsieüberwachungsgeräte in Europa
Treiber
-
Steigende Prävalenz von Epilepsie
Epilepsie ist eine neurologische Erkrankung, die grundlose, wiederkehrende Anfälle verursacht. Ein Anfall ist ein plötzlicher Anstieg abnormaler elektrischer Aktivität im Gehirn. Ärzte diagnostizieren Epilepsie, wenn jemand zwei oder mehr Anfälle ohne andere erkennbare Ursache hat. Jeder kann Epilepsie entwickeln, aber am häufigsten tritt sie bei jungen und älteren Erwachsenen auf. Ein leichter Anfall kann schwer zu erkennen sein. Er kann nur ein paar Sekunden dauern und die Person kann dabei wach bleiben. Stärkere Anfälle können Krämpfe und unkontrollierbare Muskelzuckungen verursachen. Sie können von ein paar Sekunden bis zu mehreren Minuten dauern und Verwirrung oder Bewusstlosigkeit verursachen. Danach kann sich die Person möglicherweise nicht mehr an den Anfall erinnern.
Epilepsie ist weltweit die häufigste neurologische Erkrankung in allen Altersgruppen. Da Epilepsie bei frühzeitiger Diagnose behandelbar ist, konzentrieren sich Menschen mit Epilepsiesymptomen stärker auf die Diagnose und Behandlung durch den Einsatz verschiedener technologisch fortschrittlicher Überwachungsgeräte. Infolgedessen steigt die Nachfrage nach Epilepsieüberwachungsgeräten, und die steigende Prävalenz von Epilepsie treibt das Wachstum des europäischen Marktes für Epilepsieüberwachungsgeräte voran.
-
Wachsende Präferenz für tragbare Epilepsie-Überwachungsgeräte
Bei der klinischen Epilepsie ist es eine große Herausforderung, eine Krankheit, die durch seltene Anfälle gekennzeichnet ist, auf der Grundlage von Patienten- oder Pflegeberichten und klinischen Tests von begrenzter Dauer zu diagnostizieren und zu behandeln. Die mangelnde Zuverlässigkeit von selbstberichteten Anfallstagebüchern bei vielen Menschen mit Epilepsie ist allgemein bekannt, aber diese Aufzeichnungen bleiben in der klinischen Versorgung und in therapeutischen Studien erforderlich.
Es sind mehrere tragbare Geräte auf den Markt gekommen, die Anfälle erkennen, Anfallsdaten aufzeichnen und Pflegekräfte alarmieren können. Tragbare Geräte können auch zuverlässige Vorhersagen der Anfallswahrscheinlichkeit ermöglichen und es Menschen mit Epilepsie ermöglichen, schnell wirkende Medikamente einzunehmen oder Aktivitäten im Hinblick auf einen bevorstehenden Anfall anzupassen. Daher erfreuen sich tragbare Sensorgeräte sowohl in der Allgemeinbevölkerung als auch in medizinischen Anwendungen zunehmender Beliebtheit. Daher treibt die zunehmende Vorliebe für tragbare Epilepsieüberwachungsgeräte das Wachstum des europäischen Marktes für Epilepsieüberwachungsgeräte voran.
-
Steigende staatliche Investitionen in das Epilepsieprojekt
Epilepsie ist die weltweit häufigste neurologische Erkrankung geworden, und die Sterberate ist ebenfalls gestiegen. Die Erforschung der zugrundeliegenden Ursachen von Epilepsien, einschließlich der Identifizierung von Genen für einige Formen der Epilepsie, hat zu einem erheblich besseren Verständnis dieser Erkrankungen geführt, was in Zukunft zu wirksameren Behandlungen oder sogar zu neuen Möglichkeiten zur Epilepsieprävention führen könnte.
Die Regierung legt mehr Wert auf weniger Todesfälle, eine bessere Lebensqualität für Patienten mit Epilepsie und weniger Anfälle. Dies kann durch die Kombination aus fortschrittlicher Bildgebung, kognitiven und genetischen Daten, personalisierten Behandlungsplänen und einem erfahrenen Operationsteam, falls erforderlich, erreicht werden. Daher investiert die Regierung mehr in Epilepsieprojekte, um die Infrastruktur zu verbessern und die Patienten besser zu versorgen. Daher kann dies ein treibender Faktor für das Wachstum des europäischen Marktes für Epilepsieüberwachungsgeräte sein.
Gelegenheiten
-
Technologischer Fortschritt bei Geräten zur Krankheitsüberwachung
Im Laufe der Zeit haben medizinische Geräte verschiedene technologische Veränderungen durchgemacht. Der Fortschritt bei medizinischen Geräten zur Krankheitsüberwachung umfasst die Verwendung flexibler Elektronik wie dünner Klappen oder Hautpflaster zur genauen und Echtzeitüberwachung der Vitalfunktionen. Die Validierung und Genauigkeit der von solchen Geräten aufgezeichneten Daten werden auch durch die Aktualisierung neuer Betriebssoftware und -hardware verbessert, die in diesen Geräten verwendet wird. Das fortschrittliche klappenartige Überwachungssystem wird von verschiedenen wichtigen Marktführern wie Neurava, Neuronostics, Epilepsy Alarms und anderen hergestellt. Die sofortige und präzise Bewertung der Ergebnisse in Verbindung mit der bemerkenswerten Existenz dieser Geräte aufgrund von Fortschritten steigert die Kundenpräferenz und die Akzeptanz solcher Geräte. Innovationen, die zu überlegenen Produkteigenschaften und Kosteneffizienz führen, werden daher die Marktexpansion von Epilepsieüberwachungsgeräten in Europa vorantreiben.
Innovation und technologischer Fortschritt haben medizinische Geräte in jeder Hinsicht verbessert, unter anderem durch Akkulaufzeit, geringes Gewicht, erweiterte Funktionen wie KI-Unterstützung, verbesserte Software und drahtlose Konnektivität. Der technologische Fortschritt bringt viele Vorteile für die Diagnose und therapeutische Anwendung des Patienten mit Verbesserungen bei Fernüberwachungssystemen. Somit fördert der zunehmende technologische Fortschritt das Wachstum des europäischen Marktes für Epilepsieüberwachungsgeräte.
-
Erhöhte Nachfrage nach dem nicht-invasiven und minimal-invasiven Gerät
Ein invasives Gerät ist ein komplizierter, schmerzhafter und riskanter Eingriff, da es einen direkten Eingriff in das Hirngewebe beinhaltet. Daher neigen medizinisches Fachpersonal und Patienten stark zur Verwendung nichtinvasiver und minimalinvasiver Geräte. Mit zunehmendem Bewusstsein entscheiden sich immer mehr Patienten für minimalinvasive oder nichtinvasive Verfahren. Epilepsieüberwachungsgeräte überwinden die mit der invasiven Gehirnüberwachung verbundenen Risiken und Schmerzen. Viele staatliche Initiativen konzentrieren sich auch darauf, die mit den Behandlungsmöglichkeiten für Hirnerkrankungen verbundenen Risiken zu verringern.
Einschränkungen/Herausforderungen
- Schlechtes Erstattungsszenario
Die Kostenerstattung für alle medizinischen Geräte und Dienstleistungen ist seit mehreren Jahren unter Abwärtsdruck. Auch diese Geräte stehen aufgrund der fehlenden Kostenerstattung vor einem großen Wachstumshindernis. Die Kombination von tragbaren Geräten mit KI, irrelevanter Datenerfassung und Sicherheitsproblemen bei medizinischen Geräten hat erhebliche Auswirkungen auf diese Geräte und erschwert die Kostenerstattung für diese Geräte. Die Kostenerstattung für ein Gerät kann die Fähigkeit eines Anbieters, auf eine bestimmte Technologie zuzugreifen, sowie die Bereitschaft eines Herstellers, diese bereitzustellen, erheblich beeinträchtigen. Wenn die Kostenerstattung unsicher ist, kann der Hersteller nur schwer vorhersagen, ob eine Investition in neue Technologie ausreichende Rendite abwirft. Dieser Mangel an Vorhersehbarkeit ist offensichtlich ein Hindernis für die Beschaffung von Finanzmitteln für das Unternehmen. Er beeinträchtigt außerdem Innovationen und schränkt den Zugang der Patienten zu fortschrittlichen Technologien und Lösungen ein.
Überwachungsgeräte sind zu einem wichtigen Bestandteil der Gesundheitsversorgung geworden, wenn es um die Diagnose und Prognose chronischer Krankheiten geht. Die zunehmende Anwendung von Überwachungsgeräten bei Erkrankungen wie neurologischen Erkrankungen, Diabetes, Fettleibigkeit und Herz-Kreislauf-Problemen, um nur einige zu nennen, macht sie für Gesundheitseinrichtungen unverzichtbar. Die hohen Kosten solcher Geräte und die fehlende angemessene Kostenerstattung behindern jedoch die Akzeptanz dieser medizinischen Geräte. Daher stellt die fehlende Kostenerstattung eine Herausforderung für das Wachstum des europäischen Marktes für Epilepsieüberwachung dar.
Auswirkungen von COVID-19 auf den europäischen Markt für molekulare Diagnostikdienste
Die Zeit nach COVID-19 hat sich negativ auf den Markt ausgewirkt. Ein großer Teil der Bevölkerung war von dieser Pandemie betroffen. Die Versorgung mit ophthalmischen Produkten wurde durch die COVID-19-Pandemie in Europa massiv beeinträchtigt. Dieser Angebotsrückgang ist hauptsächlich auf verschiedene Quarantänemaßnahmen zurückzuführen, die von Ländern weltweit eingeführt wurden. Dies sind neben Bewegungseinschränkungen und Arbeitskräfteabbau die Hauptgründe für einen rückläufigen Trend auf dem Versorgungsmarkt für medizinische Geräte. Dies hat die Qualität und Wirksamkeit medizinischer Geräte in hohem Maße beeinträchtigt. Der Personalabbau aufgrund der COVID-19-Erkrankung ist ein weiterer Faktor, der zur Verringerung des Angebots an Epilepsieüberwachungsgeräten beiträgt.
Jüngste Entwicklungen
- Im Dezember 2022 kündigte die NIHON KOHDEN CORPORATION die Eröffnung einer neuen Verkaufsniederlassung von Nihon Kohden Singapore (NKS), einer ihrer Vertriebstochtergesellschaften, an, mit dem Ziel, die Registrierung von Medizinprodukten reibungslos zu beantragen und ihren Vertrieb auf den Philippinen auszuweiten.
- Im Februar 2022 gab Masimo den Abschluss einer endgültigen Fusionsvereinbarung zur Übernahme der Viper Holdings Corporation bekannt, der Sound United („Sound United“) gehört. Dieses Unternehmen für Verbrauchertechnologie besitzt ein Portfolio von Premiummarken, darunter Bowers & Wilkins, Denon, Polk Audio und Marantz. Gemäß der Fusionsvereinbarung mussten sie für die Übernahme vorbehaltlich Anpassungen rund 1,025 Milliarden USD zahlen. Dies hilft dem Unternehmen, mehr Umsatz zu erzielen
Marktumfang für Epilepsieüberwachungsgeräte in Europa
Der europäische Markt für Epilepsieüberwachungsgeräte ist in fünf wichtige Segmente unterteilt, basierend auf Produkttyp, Typ, Patiententyp, Endbenutzer und Vertriebskanal. Das Wachstum dieser Segmente hilft Ihnen bei der Analyse schwacher Wachstumssegmente in den Branchen und bietet den Benutzern einen wertvollen Marktüberblick und Markteinblicke, um strategische Entscheidungen zur Identifizierung der wichtigsten Marktanwendungen zu treffen.
Nach Produkttyp
- Tragbare Geräte
- Intelligente Geräte
- Konventionelle Geräte
Auf der Grundlage des Produkttyps ist der Markt in tragbare Geräte, intelligente Geräte und herkömmliche Geräte segmentiert.
Nach Typ
- Fokale Anfälle
- Generalisierte Anfälle
Auf der Grundlage des Typs ist der Markt in fokale Anfälle und generalisierte Anfälle segmentiert.
Nach Patiententyp
- Pädiatrie
- Geriatrie
- Erwachsene
Auf der Grundlage des Patiententyps wird der Markt in Kinder, Geriatrie und Erwachsene segmentiert.
Nach Endbenutzer
- Krankenhäuser
- Häusliche Pflege
- Neurologische Zentren
- Diagnostikzentren
- Ambulante chirurgische Zentren und Kliniken
- Sonstiges
Auf der Grundlage der Endbenutzer wird der Markt in Krankenhäuser, Einrichtungen der häuslichen Pflege, neurologische Zentren, Diagnosezentren, ambulante chirurgische Zentren und Kliniken und andere segmentiert.
Nach Vertriebskanal
- Einzelhandelsumsätze
- Online-Verkäufe
- Direkte Ausschreibungen
- Sonstiges
Auf der Grundlage der Vertriebskanäle wird der Markt in Einzelhandelsverkäufe, Online-Verkäufe, Direktausschreibungen und Sonstiges segmentiert.
Europa Epilepsie-Überwachungsgeräte Markt Regionale Analyse/Einblicke
Der europäische Markt für Epilepsieüberwachungsgeräte wird analysiert und Einblicke und Trends in die Marktgröße werden nach Land, Produkttyp, Typ, Patiententyp, Endbenutzer und Vertriebskanal bereitgestellt.
Die vom europäischen Markt für Epilepsieüberwachungsgeräte abgedeckten Länder sind Deutschland, Großbritannien, Frankreich, Italien, Spanien, Russland, die Niederlande, die Schweiz, Belgien, die Türkei, Dänemark, Schweden, Norwegen, Polen, Finnland und das übrige Europa.
Deutschland dominiert den europäischen Markt für Epilepsieüberwachungsgeräte aufgrund der Zunahme der Marktteilnehmer und der Verfügbarkeit verschiedener fortschrittlicher Epilepsieüberwachungsgeräte auf dem Markt. Darüber hinaus hat die Zahl staatlicher und privater Kooperationen auf dem Markt zugenommen, was das Marktwachstum weiter ankurbelt. Die hohen Kosten, die mit komplexen Epilepsieüberwachungsgeräten und -verfahren verbunden sind, könnten das Marktwachstum im Prognosezeitraum jedoch hemmen.
Der Länderabschnitt des Berichts enthält auch einzelne marktbeeinflussende Faktoren und Änderungen der Regulierungen auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Markttrends auswirken. Datenpunkte wie Neuverkäufe, Ersatzverkäufe, Länderdemografie, Krankheitsepidemiologie und Import-Export-Zölle sind einige der wichtigsten Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Prognoseanalyse der Länderdaten werden auch die Präsenz und Verfügbarkeit globaler Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken berücksichtigt, die sich auf die Vertriebskanäle auswirken.
Wettbewerbsumfeld und Marktanteilsanalyse für Epilepsieüberwachungsgeräte in Europa
Die Wettbewerbslandschaft des europäischen Marktes für Epilepsieüberwachungsgeräte liefert Einzelheiten zu den Wettbewerbern. Zu den Details gehören Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, Präsenz in Europa, Produktionsstandorte und -anlagen, Produktionskapazitäten, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktbreite und -umfang sowie Anwendungsdominanz. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus des Unternehmens auf den Markt.
Zu den wichtigsten Akteuren auf dem europäischen Markt für Epilepsieüberwachungsgeräte zählen unter anderem NIHON KOHDEN CORPORATION., Masimo, Apple Inc., Natus Medical Incorporated., Owlet, Neurotech, LLC, SmartMonitor und Epilert.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE EPILEPSY MONITORING DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 EUROPE EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PREMIUM INSIGHTS
4.1.1 KEY STRATEGIC INITIATIVES
4.1.2 SEIZURES OCCURRENCE, BY TIME
4.1.2.1 DURING DAY
4.1.2.2 DURING SLEEP
4.1.2.2.1 RAPID EYE MOVEMENT (REM) SLEEP
4.1.2.2.2 NON-REM SLEEP
4.1.2.3 DURING NIGHT
5 EPIDEMIOLOGY
5.1 INCIDENCE & PREVALENCE OF EPILEPSY, BY COUNTRY
5.1.1 GENERALIZED SEIZURES, BY PATIENT TYPE
5.1.1.1 TONIC-CLONIC SEIZURES
5.1.1.2 ABSENCE SEIZURES
5.1.2 FOCAL SEIZURES, BY PATIENT TYPE
5.1.2.1 SIMPLE FOCAL SEIZURES
5.1.2.2 COMPLEX FOCAL SEIZURES
5.1.2.3 SECONDARY GENERALIZED SEIZURES
6 EUROPE EPILEPSY MONITORING DEVICE MARKET, REGULATORY FRAMEWORK
6.1 MEDICAL DEVICES
6.2 WEARABLE MEDICAL DEVICES
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF EPILEPSY
7.1.2 GROWING PREFERENCE FOR WEARABLE EPILEPSY MONITORING DEVICES
7.1.3 RISING GOVERNMENT INVESTMENTS IN THE EPILEPSY PROJECT
7.1.4 INCREASED R & D ACTIVITIES IN EPILEPSY
7.2 RESTRAINTS
7.2.1 HIGH COST ASSOCIATED WITH COMPLEX EPILEPSY MONITORING PROCEDURES & DEVICES
7.2.2 PRODUCT RECALL SCENARIO OF EPILEPSY MONITORING DEVICES
7.3 OPPORTUNITIES
7.3.1 RISE IN TECHNOLOGY ADVANCEMENT IN DISEASE MONITORING DEVICE
7.3.2 INCREASED DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE DEVICE
7.4 CHALLENGES
7.4.1 POOR REIMBURSEMENT SCENARIO
7.4.2 STRINGENT RULES & REGULATIONS FOR PRODUCT APPROVAL
8 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 WEARABLE DEVICES
8.2.1 SMART WATCHES
8.2.2 OTHER NON-INVASIVE MONITORING DEVICES
8.3 SMART DEVICES
8.3.1 MOTION MONITORS
8.3.2 1.3.2 VIDEO MONITORS
8.3.3 MATTRESS DEVICES
8.3.4 OTHERS
8.4 CONVENTIONAL DEVICES
8.4.1 EEG DEVICE
8.4.1.1 AMBULATORY EEG
8.4.1.2 CONTINUOUS EEG
8.4.1.3 OTHER EEG DEVICES
8.4.2 ELECTROMYOGRAPHY (EMG) DEVICE
8.4.3 ELECTROCARDIOGRAM (ECG) DEVICE
8.4.4 PULSE- OXIMETERS
8.4.5 IMPLANTED ADVISORY SYSTEM
8.4.6 TRIAXIAL ACCELEROMETER (ACM)
8.4.7 MAGNETOMETERS
8.4.8 OTHER DEVICES
9 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY TYPE
9.1 OVERVIEW
9.2 FOCAL SEIZURES
9.2.1 SIMPLE FOCAL SEIZURES
9.2.1.1 SMART DEVICES
9.2.1.2 WEARABLE DEVICES
9.2.1.3 CONVENTIONAL DEVICES
9.2.2 COMPLEX FOCAL SEIZURES
9.2.2.1 SMART DEVICES
9.2.2.2 WEARABLE DEVICES
9.2.2.3 CONVENTIONAL DEVICES
9.2.3 SECONDARY GENERALIZED SEIZURES
9.2.3.1 SMART DEVICES
9.2.3.2 WEARABLE DEVICES
9.2.3.3 CONVENTIONAL DEVICES
9.3 GENERALIZED SEIZURES
9.3.1 TONIC-CLONIC SEIZURES
9.3.1.1 SMART DEVICES
9.3.1.2 WEARABLE DEVICES
9.3.1.3 CONVENTIONAL DEVICES
9.3.2 ABSENCE SEIZURES
9.3.2.1 SMART DEVICES
9.3.2.2 WEARABLE DEVICES
9.3.2.3 CONVENTIONAL DEVICES
10 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE
10.1 OVERVIEW
10.2 PEDIATRIC
10.3 GERIATRIC
10.4 ADULTS
11 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 HOMECARE SETTINGS
11.4 NEUROLOGY CENTRES
11.5 DIAGNOSTIC CENTRES
11.6 AMBULATORY SURGICAL CENTRES AND CLINICS
11.7 OTHERS
12 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 RETAIL SALES
12.3 ONLINE SALES
12.4 DIRECT TENDERS
12.5 OTHERS
13 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY REGION
13.1 EUROPE
13.1.1 GERMANY
13.1.2 U.K.
13.1.3 FRANCE
13.1.4 ITALY
13.1.5 SPAIN
13.1.6 RUSSIA
13.1.7 NETHERLANDS
13.1.8 SWITZERLAND
13.1.9 BELGIUM
13.1.10 TURKEY
13.1.11 DENMARK
13.1.12 SWEDEN
13.1.13 NORWAY
13.1.14 POLAND
13.1.15 FINLAND
13.1.16 REST OF EUROPE
14 EUROPE EPILEPSY MONITORING DEVICES MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT
16 COMPANY PROFILES
16.1 NIHON KOHDEN CORPORATION.
16.1.1 COMPANY SNAPSHOT
16.1.2 RECENT FINANCIALS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 MASIMO
16.2.1 COMPANY SNAPSHOT
16.2.2 RECENT FINANCIALS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 APPLE INC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 NATUS MEDICAL INCORPORATED.
16.4.1 COMPANY SNAPSHOT
16.4.2 RECENT FINANCIALS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 OWLET.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENT
16.6 ACTIGRAPH, LLC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 ADVANCED BRAIN MONITORING, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 CAPTUREPROFF INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 EMPATICA INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 EPIHUNTER
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 EPILERT
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 EPILEPSY ALARMS UK
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 EPI USA.
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 EPIVIEW
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 FREQUENCY PRECISION.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 HIPASS DESIGN LLC
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 IBABY LABS, INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 ITS DESIGNS LTD
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 LIVASSURED
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 LIVELIFE ALARMS.
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 MEDPAGE LTD
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 MIKU INC.
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENT
16.23 NEUROSOFT
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENTS
16.24 NEUROTECH, LLC
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 SAFE-LIFE
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 SMARTMONITOR
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENT
16.27 SNUZA
16.27.1 COMPANY SNAPSHOT
16.27.2 PRODUCT PORTFOLIO
16.27.3 RECENT DEVELOPMENT
16.28 THE ‘LIFE MINDER’
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
16.29 VAHLKAMP INTERNATIONAL B.V.
16.29.1 COMPANY SNAPSHOT
16.29.2 PRODUCT PORTFOLIO
16.29.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS)
TABLE 2 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS)
TABLE 3 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS)
TABLE 4 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 EUROPE WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 EUROPE WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 EUROPE SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 EUROPE SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 EUROPE CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 EUROPE CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 EUROPE EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 13 EUROPE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 EUROPE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 15 EUROPE SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 16 EUROPE COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 17 EUROPE SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 18 EUROPE GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 EUROPE GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 20 EUROPE TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION))
TABLE 21 EUROPE ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 22 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 23 EUROPE PEDIATRIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 EUROPE GERIATRIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 EUROPE ADULTS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 27 EUROPE HOSPITALS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 EUROPE HOMECARE SETTINGS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 EUROPE NEUROLOGY CENTERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 EUROPE DIAGNOSTIC CENTERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 EUROPE AMBULATORY SURGICAL CENTRES AND CLINIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 EUROPE OTHERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 34 EUROPE RETAIL SALES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 EUROPE ONLINE SALES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 EUROPE DIRECT TENDERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 EUROPE OTHERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 39 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 40 EUROPE WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 EUROPE WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 42 EUROPE WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 43 EUROPE SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 44 EUROPE SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 45 EUROPE SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 46 EUROPE CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 47 EUROPE CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 48 EUROPE CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 49 EUROPE EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 50 EUROPE EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 51 EUROPE EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 52 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 53 EUROPE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 EUROPE SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 55 EUROPE COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 56 EUROPE SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 57 EUROPE GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 58 EUROPE TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 59 EUROPE ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 60 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 61 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 62 EUROPE EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 63 GERMANY EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 GERMANY WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 GERMANY WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 66 GERMANY WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 67 GERMANY SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 GERMANY SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 69 GERMANY SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 70 GERMANY CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 71 GERMANY CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 72 GERMANY CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 73 GERMANY EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 74 GERMANY EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 75 GERMANY EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 76 GERMANY EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 GERMANY FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 GERMANY SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 GERMANY COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 GERMANY SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 81 GERMANY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 82 GERMANY TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 83 GERMANY ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 84 GERMANY EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 85 GERMANY EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 86 GERMANY EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 87 U.K. EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 88 U.K. WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 89 U.K. WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 90 U.K. WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 91 U.K. SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 92 U.K. SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 93 U.K. SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 94 U.K. CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 95 U.K. CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 96 U.K. CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 97 U.K. EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 U.K. EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 99 U.K. EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 100 U.K. EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 U.K. FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 U.K. SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 103 U.K. COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 104 U.K. SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 105 U.K. GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 U.K. TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 107 U.K. ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 108 U.K. EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 109 U.K. EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 110 U.K. EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 111 FRANCE EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 112 FRANCE WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 FRANCE WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 114 FRANCE WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 115 FRANCE SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 FRANCE SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 117 FRANCE SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 118 FRANCE CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 FRANCE CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 120 FRANCE CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 121 FRANCE EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 FRANCE EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 123 FRANCE EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 124 FRANCE EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 125 FRANCE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 126 FRANCE SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 FRANCE COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 128 FRANCE SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 FRANCE GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 FRANCE TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 131 FRANCE ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 132 FRANCE EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 133 FRANCE EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 134 FRANCE EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 135 ITALY EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 ITALY WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 137 ITALY WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 138 ITALY WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 139 ITALY SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 140 ITALY SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 141 ITALY SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 142 ITALY CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 143 ITALY CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 144 ITALY CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 145 ITALY EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 146 ITALY EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 147 ITALY EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 148 ITALY EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 149 ITALY FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 150 ITALY SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 151 ITALY COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 152 ITALY SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 153 ITALY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 ITALY TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 155 ITALY ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 156 ITALY EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 157 ITALY EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 158 ITALY EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 159 SPAIN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 SPAIN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 SPAIN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 162 SPAIN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 163 SPAIN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 SPAIN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 165 SPAIN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 166 SPAIN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 SPAIN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 168 SPAIN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 169 SPAIN EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 170 SPAIN EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 171 SPAIN EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 172 SPAIN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 173 SPAIN FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 174 SPAIN SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 175 SPAIN COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 176 SPAIN SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 177 SPAIN GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 178 SPAIN TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 179 SPAIN ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 180 SPAIN EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 181 SPAIN EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 182 SPAIN EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 183 RUSSIA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 RUSSIA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 185 RUSSIA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 186 RUSSIA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 187 RUSSIA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 188 RUSSIA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 189 RUSSIA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 190 RUSSIA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 191 RUSSIA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 192 RUSSIA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 193 RUSSIA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 194 RUSSIA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 195 RUSSIA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 196 RUSSIA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 197 RUSSIA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 198 RUSSIA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 199 RUSSIA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 200 RUSSIA SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 201 RUSSIA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 202 RUSSIA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 203 RUSSIA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 204 RUSSIA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 205 RUSSIA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 206 RUSSIA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 207 NETHERLANDS EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 208 NETHERLANDS WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 209 NETHERLANDS WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 210 NETHERLANDS WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 211 NETHERLANDS SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 NETHERLANDS SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 213 NETHERLANDS SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 214 NETHERLANDS CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 NETHERLANDS CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 216 NETHERLANDS CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 217 NETHERLANDS EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 NETHERLANDS EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 219 NETHERLANDS EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 220 NETHERLANDS EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 221 NETHERLANDS FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 222 NETHERLANDS SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 223 NETHERLANDS COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 224 NETHERLANDS SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 225 NETHERLANDS GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 226 NETHERLANDS TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 227 NETHERLANDS ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 228 NETHERLANDS EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 229 NETHERLANDS EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 230 NETHERLANDS EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 231 SWITZERLAND EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 232 SWITZERLAND WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 233 SWITZERLAND WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 234 SWITZERLAND WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 235 SWITZERLAND SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 236 SWITZERLAND SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 237 SWITZERLAND SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 238 SWITZERLAND CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 239 SWITZERLAND CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 240 SWITZERLAND CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 241 SWITZERLAND EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 242 SWITZERLAND EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 243 SWITZERLAND EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 244 SWITZERLAND EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 245 SWITZERLAND FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 246 SWITZERLAND SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 247 SWITZERLAND COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 248 SWITZERLAND SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 249 SWITZERLAND GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 250 SWITZERLAND TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 251 SWITZERLAND ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 252 SWITZERLAND EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 253 SWITZERLAND EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 254 SWITZERLAND EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 255 BELGIUM EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 256 BELGIUM WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 257 BELGIUM WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 258 BELGIUM WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 259 BELGIUM SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 260 BELGIUM SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 261 BELGIUM SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 262 BELGIUM CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 263 BELGIUM CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 264 BELGIUM CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 265 BELGIUM EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 266 BELGIUM EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 267 BELGIUM EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 268 BELGIUM EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 269 BELGIUM FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 270 BELGIUM SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 271 BELGIUM COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 272 BELGIUM SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 273 BELGIUM GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 274 BELGIUM TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 275 BELGIUM ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 276 BELGIUM EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 277 BELGIUM EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 278 BELGIUM EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 279 TURKEY EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 280 TURKEY WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 281 TURKEY WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 282 TURKEY WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 283 TURKEY SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 284 TURKEY SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 285 TURKEY SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 286 TURKEY CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 287 TURKEY CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 288 TURKEY CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 289 TURKEY EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 290 TURKEY EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 291 TURKEY EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 292 TURKEY EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 293 TURKEY FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 294 TURKEY SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 295 TURKEY COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 296 TURKEY SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 297 TURKEY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 298 TURKEY TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 299 TURKEY ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 300 TURKEY EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 301 TURKEY EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 302 TURKEY EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 303 DENMARK EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 304 DENMARK WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 305 DENMARK WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 306 DENMARK WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 307 DENMARK SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 308 DENMARK SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 309 DENMARK SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 310 DENMARK CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 311 DENMARK CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 312 DENMARK CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 313 DENMARK EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 314 DENMARK EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 315 DENMARK EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 316 DENMARK EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 317 DENMARK FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 318 DENMARK SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 319 DENMARK COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 320 DENMARK SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 321 DENMARK GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 322 DENMARK TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 323 DENMARK ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 324 DENMARK EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 325 DENMARK EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 326 DENMARK EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 327 SWEDEN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 328 SWEDEN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 329 SWEDEN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 330 SWEDEN WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 331 SWEDEN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 332 SWEDEN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 333 SWEDEN SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 334 SWEDEN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 335 SWEDEN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 336 SWEDEN CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 337 SWEDEN EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 338 SWEDEN EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 339 SWEDEN EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 340 SWEDEN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 341 SWEDEN FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 342 SWEDEN SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 343 SWEDEN COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 344 SWEDEN SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 345 SWEDEN GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 346 SWEDEN TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 347 SWEDEN ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 348 SWEDEN EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 349 SWEDEN EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 350 SWEDEN EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 351 NORWAY EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 352 NORWAY WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 353 NORWAY WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 354 NORWAY WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 355 NORWAY SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 356 NORWAY SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 357 NORWAY SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 358 NORWAY CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 359 NORWAY CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 360 NORWAY CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 361 NORWAY EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 362 NORWAY EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 363 NORWAY EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 364 NORWAY EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 365 NORWAY FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 366 NORWAY SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 367 NORWAY COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 368 NORWAY SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 369 NORWAY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 370 NORWAY TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 371 NORWAY ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 372 NORWAY EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 373 NORWAY EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 374 NORWAY EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 375 POLAND EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 376 POLAND WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 377 POLAND WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 378 POLAND WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 379 POLAND SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 380 POLAND SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 381 POLAND SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 382 POLAND CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 383 POLAND CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 384 POLAND CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 385 POLAND EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 386 POLAND EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 387 POLAND EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 388 POLAND EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 389 POLAND FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 390 POLAND SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 391 POLAND COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 392 POLAND SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 393 POLAND GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 394 POLAND TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 395 POLAND ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 396 POLAND EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 397 POLAND EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 398 POLAND EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 399 FINLAND EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 400 FINLAND WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 401 FINLAND WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 402 FINLAND WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 403 FINLAND SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 404 FINLAND SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 405 FINLAND SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 406 FINLAND CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 407 FINLAND CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 408 FINLAND CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 409 FINLAND EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 410 FINLAND EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT)
TABLE 411 FINLAND EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 412 FINLAND EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 413 FINLAND FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 414 FINLAND SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 415 FINLAND COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 416 FINLAND SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 417 FINLAND GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 418 FINLAND TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 419 FINLAND ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 420 FINLAND EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION)
TABLE 421 FINLAND EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 422 FINLAND EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 423 REST OF EUROPE EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 EUROPE EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION
FIGURE 2 EUROPE EPILEPSY MONITORING DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE EPILEPSY MONITORING DEVICES MARKET: DROC ANALYSIS
FIGURE 4 EUROPE EPILEPSY MONITORING DEVICES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE EPILEPSY MONITORING DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE EPILEPSY MONITORING DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE EPILEPSY MONITORING DEVICES MARKET: DBMR POSITION GRID
FIGURE 8 EUROPE EPILEPSY MONITORING DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 EUROPE EPILEPSY MONITORING DEVICES MARKET: END USER COVERAGE GRID
FIGURE 10 EUROPE EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION
FIGURE 11 THE RISING PREVALENCE OF EPILEPSY & GROWING PREFERENCE FOR WEARABLE EPILEPSY MONITORING DEVICES ARE EXPECTED TO DRIVE THE EUROPE EPILEPSY MONITORING DEVICES MARKET FROM 2023 TO 2030
FIGURE 12 THE WEARABLE DEVICE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE EUROPE EPILEPSY MONITORING DEVICES MARKET FROM 2023 TO 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE EUROPE EPILEPSY MONITORING DEVICES MARKET
FIGURE 14 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 EUROPE EPILEPSY MONITORING DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY TYPE, 2022
FIGURE 19 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 21 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, 2022
FIGURE 23 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE 2023-2030 (USD MILLION)
FIGURE 24 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, CAGR (2023-2030)
FIGURE 25 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 26 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY END USER, 2022
FIGURE 27 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 EUROPE EPILEPSY MONITORING DEVICES MARKET: SNAPSHOT (2022)
FIGURE 35 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022)
FIGURE 36 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 EUROPE EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 EUROPE EPILEPSY MONITORING DEVICES MARKET: PRODUCT TYPE (2023-2030)
FIGURE 39 EUROPE EPILEPSY MONITORING DEVICES MARKET: COMPANY SHARE 2022 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
